Alum adjuvant: some of the tricks of the oldest adjuvant
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Alum has been the most widely used adjuvant for over 80 years. Although there have been searches for alternative adjuvants, aluminium-containing adjuvants will continue to be used for many years due to their good track record of safety, low cost and adjuvanticity with a variety of antigens. For infections that can be prevented by induction of serum antibodies, aluminium-containing adjuvants formulated under optimal conditions are the adjuvants of choice. There are also some limitations of aluminium-containing adjuvants, which include local reactions, augmentation of IgE antibody responses, ineffectiveness for some antigens and inability to augment cell-mediated immune responses, especially cytotoxic T-cell responses. In this review, we describe the current knowledge regarding the mechanisms (both cellular and molecular) by which alum employs its adjuvant effect, although the final mechanism is not yet well-defined. Furthermore, we discuss how alum's adjuvanticity could be improved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Toll-like receptors in innate immunity
Takeda, K. (2004) · International Immunology · doi:10.1093/intimm/dxh186 · Cited by 3,328
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Neutrophils in the activation and regulation of innate and adaptive immunity
Mantovani, A., Cassatella, M. A., Costantini, C., & Jaillon, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri3024 · Cited by 3,027
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A. (2008) · Nature · doi:10.1038/nature06939 · Cited by 1,542
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
Pétrilli, V, Papin, S., Dostert, C., Mayor, A., Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402195 · Cited by 1,445
Toll-like receptors control activation of adaptive immune responses
Schnare, M., Barton, G. M., Holt, A. C., Takeda, K., Akira, S., & Medzhitov, R. (2001) · Nature Immunology · doi:10.1038/ni712 · Cited by 1,365
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 993
Self-citationInflammasome adaptors and sensors: intracellular regulators of infection and inflammation
Mariathasan, S., & Monack, D. M. (2007) · Nature Reviews Immunology · doi:10.1038/nri1997 · Cited by 869
Didierlaurent, A. M., Morel, S., Lockman, L., Giannini, S. L., Bisteau, M., Carlsen, H., Kielland, A., Vosters, O., Vanderheyde, N., Schiavetti, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901474 · Cited by 758
Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation
Krysko, D. V., Agostinis, P., Krysko, O., Garg, A. D., Bachert, C., Lambrecht, B. N., & Vandenabeele, P. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.01.005 · Cited by 680
Self-citationCutting Edge: Inflammasome Activation by Alum and Alum’s Adjuvant Effect Are Mediated by NLRP3
Li, H., Willingham, S. B., Ting, J. P.-Y., & Re, F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.17 · Cited by 675
Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells
Idzko, M., Hammad, H., van Nimwegen, M., Kool, M., Willart, M. A. M., Muskens, F., Hoogsteden, H. C., Luttmann, W., Ferrari, D., Di Virgilio, F., et al. (2007) · Nature Medicine · doi:10.1038/nm1617 · Cited by 620
Self-citationKool, M., Pétrilli, V., De Smedt, T., Rolaz, A., Hammad, H., van Nimwegen, M., Bergen, I. M., Castillo, R., Lambrecht, B. N., & Tschopp, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3755 · Cited by 611
Self-citationAdjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
Gavin, A. L., Hoebe, K., Duong, B., Ota, T., Martin, C., Beutler, B., & Nemazee, D. (2006) · Science · doi:10.1126/science.1135299 · Cited by 581
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
Sharp, F. A., Ruane, D., Claass, B., Creagh, E., Harris, J., Malyala, P., Singh, M., O'Hagan, D. T., Pétrilli, V., Tschopp, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804897106 · Cited by 540
DNA released from dying host cells mediates aluminum adjuvant activity
Marichal, T., Ohata, K., Bedoret, D., Mesnil, C., Sabatel, C., Kobiyama, K., Lekeux, P., Coban, C., Akira, S., Ishii, K. J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2403 · Cited by 535
Steinhagen, F., Kinjo, T., Bode, C., & Klinman, D. M. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.08.002 · Cited by 501
Leroux-Roels, I., Borkowski, A., Vanwolleghem, T., Dramé, M., Clement, F., Hons, E., Devaster, J.-M., & Leroux-Roels, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61297-5 · Cited by 498
Molecular and cellular signatures of human vaccine adjuvants
Mosca, F., Tritto, E., Muzzi, A., Monaci, E., Bagnoli, F., Iavarone, C., O'Hagan, D., Rappuoli, R., & De Gregorio, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804699105 · Cited by 492
Franchi, L., & Núñez, G. (2008) · European Journal of Immunology · doi:10.1002/eji.200838549 · Cited by 450
Use of defined TLR ligands as adjuvants within human vaccines
Duthie, M. S., Windish, H. P., Fox, C. B., & Reed, S. G. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00978.x · Cited by 437
Neutrophil secretion products pave the way for inflammatory monocytes
Soehnlein, O., Zernecke, A., Eriksson, E. E., Rothfuchs, A. G., Pham, C. T., Herwald, H., Bidzhekov, K., Rottenberg, M. E., Weber, C., & Lindbom, L. (2008) · Blood · doi:10.1182/blood-2008-02-139634 · Cited by 436
Calabro, S., Tortoli, M., Baudner, B. C., Pacitto, A., Cortese, M., O’Hagan, D. T., De Gregorio, E., Seubert, A., & Wack, A. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.12.090 · Cited by 433
Sokal, E. M., Hoppenbrouwers, K., Vandermeulen, C., Moutschen, M., Léonard, P., Moreels, A., Haumont, M., Bollen, A., Smets, F., & Denis, M. (2007) · The Journal of Infectious Diseases · doi:10.1086/523813 · Cited by 426
Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity
Flach, T. L., Ng, G., Hari, A., Desrosiers, M. D., Zhang, P., Ward, S. M., Seamone, M. E., Vilaysane, A., Mucsi, A. D., Fong, Y., et al. (2011) · Nature Medicine · doi:10.1038/nm.2306 · Cited by 405
McKee, A. S., Munks, M. W., MacLeod, M. K. L., Fleenor, C. J., Van Rooijen, N., Kappler, J. W., & Marrack, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900164 · Cited by 392
Kool, M., Willart, M. A. M., van Nimwegen, M., Bergen, I., Pouliot, P., Virchow, J. C., Rogers, N., Osorio, F., Reis e Sousa, C., Hammad, H., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.015 · Cited by 357
Self-citationMechanism of action of clinically approved adjuvants
Lambrecht, B. N., Kool, M., Willart, M. A., & Hammad, H. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.004 · Cited by 354
Self-citationAluminum Hydroxide Adjuvants Activate Caspase-1 and Induce IL-1β and IL-18 Release
Li, H., Nookala, S., & Re, F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5271 · Cited by 332
Antigen depot is not required for alum adjuvanticity
Hutchison, S., Benson, R. A., Gibson, V. B., Pollock, A. H., Garside, P., & Brewer, J. M. (2012) · The FASEB Journal · doi:10.1096/fj.11-184556 · Cited by 244
Brewer, J. M., Conacher, M., Satoskar, A., Bluethmann, H., & Alexander, J. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260915 · Cited by 232
Mechanism of action of licensed vaccine adjuvants
Tritto, E., Mosca, F., & De Gregorio, E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.084 · Cited by 213
Schijns, V. E., & Lavelle, E. C. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.21 · Cited by 211
Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo.
Sornasse, T., Flamand, V, De Becker, G., Bazin, H., Tielemans, F., Thielemans, K., Urbain, J., Leo, O., & Moser, M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.1.15 · Cited by 211
Kuroda, E., Ishii, K. J., Uematsu, S., Ohata, K., Coban, C., Akira, S., Aritake, K., Urade, Y., & Morimoto, Y. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.019 · Cited by 207
Review of the macrophage disappearance reaction
Barth, M. W., Hendrzak, J. A., Melnicoff, M. J., & Morahan, P. S. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.3.361 · Cited by 197
New hepatitis B vaccine formulated with an improved adjuvant system
Kundi, M. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.2.133 · Cited by 193
Mannhalter, J. W., Neychev, H., Zlabinger, G. J., Ahmad, R., & Eibl, M. M. (1985) · PubMed Central · Cited by 183
Yang, C.-W., Strong, B. S. I., Miller, M. J., & Unanue, E. R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001289 · Cited by 177
Bendelac, A., & Medzhitov, R. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020073 · Cited by 158
New insights into the mechanism of IL-1β maturation
Burns, K., Martinon, F., & Tschopp, J. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00017-1 · Cited by 142
Nlrp3: An immune sensor of cellular stress and infection
Lamkanfi, M., & Kanneganti, T.-D. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.01.008 · Cited by 140
Cervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer
Wu, T.-C. (2008) · Biologics: Targets & Therapy · doi:10.2147/btt.s1877 · Cited by 139
Ueda, Y., Cain, D. W., Kuraoka, M., Kondo, M., & Kelsoe, G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803961 · Cited by 138
Goto, N., Kato, H., Maeyama, J., Shibano, M., Saito, T., Yamaguchi, J., & Yoshihara, S. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00054-6 · Cited by 136
Pivotal Advance: Eosinophils mediate early alum adjuvant-elicited B cell priming and IgM production
Wang, H.-B., & Weller, P. F. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607392 · Cited by 119
Toll-like receptors and antibody responses
Nemazee, D. A., Gavin, A. L., Hoebe, K. H. N., & Beutler, B. (2006) · Nature · doi:10.1038/nature04875 · Cited by 97
Sacerdote, P., Manfredi, B., Gaspani, L., & Panerai, A. E. (2000) · Blood · doi:10.1182/blood.v95.6.2031 · Cited by 94
Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo
Munks, M. W., McKee, A. S., MacLeod, M. K. L., Powell, R. L., Degen, J. L., Reisdorph, N. A., Kappler, J. W., & Marrack, P. (2010) · Blood · doi:10.1182/blood-2010-03-275529 · Cited by 93
Histopathological Studies of Reactions in Mice Injected with Aluminum‐Adsorbed Tetanus Toxoid
Goto, N., & Akama, K. (1982) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1982.tb00261.x · Cited by 89
Immunostimulatory activity of haptenated proteins
Palm, N. W., & Medzhitov, R. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809403105 · Cited by 84
Shi, Y., HogenEsch, H., & Hem, S. L. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00313-9 · Cited by 65
Chronic morphine administration impairs cell-mediated immune responses in swine.
Molitor, T. W., Morilla, A., Risdahl, J. M., Murtaugh, M. P., Chao, C., & Peterson, P. K. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11336-0 · Cited by 65
Sacerdote, P., Gaspani, L., & Panerai, A. E. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05440.x · Cited by 47
Robinson, R., Khader, S. A., Locksley, R. M., Lien, E., Smiley, S. T., & Cooper, A. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5560 · Cited by 47
Huber, M., Beuscher, H. U., Rohwer, P., Kurrle, R., Röllinghoff, M., & Lohoff, M. D. (1998) · PubMed · Cited by 38
Huber, M., Beuscher, H. U., Rohwer, P., Kurrle, R., Röllinghoff, M., & Lohoff, M. D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4242 · Cited by 38
McKee, A. S., MacLeod, M. K. L., White, J., Crawford, F., Kappler, J. W., & Marrack, P. (2008) · International Immunology · doi:10.1093/intimm/dxn025 · Cited by 37
Yang, C., Shi, H., Zhou, J., Liang, Y., & Xu, H. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.047 · Cited by 30
Heijmans, S., Meulemeester, M. D., Reynders, P., Giet, D., Demanet, E., Devresse, P.-Y., Icardi, G., Dramé, M., Roman, F. P., & Gillard, P. H. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq174 · Cited by 30
Carpenter, G. W., & Carr, D. J. J. (1995) · Immunopharmacology · doi:10.1016/0162-3109(94)00052-h · Cited by 29
Local histopathological reactions to aluminum-adsorbed tetanus toxoid
Goto, N., & Akama, K. (1984) · Die Naturwissenschaften · doi:10.1007/bf00365894 · Cited by 15
Cited by
Key roles of adjuvants in modern vaccines
Reed, S. G., Orr, M. T., & Fox, C. B. (2013) · Nature Medicine · doi:10.1038/nm.3409 · Cited by 1,419
Modern Subunit Vaccines: Development, Components, and Research Opportunities
Moyle, P. M., & Toth, I. (2013) · ChemMedChem · doi:10.1002/cmdc.201200487 · Cited by 464
Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths
Gause, W. C., Wynn, T. A., & Allen, J. E. (2013) · Nature Reviews Immunology · doi:10.1038/nri3476 · Cited by 464
Mechanism of Immunopotentiation and Safety of Aluminum Adjuvants
HogenEsch, H. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00406 · Cited by 430
Tam, H. H., Melo, M. B., Kang, M., Pelet, J. M., Ruda, V. M., Foley, M. H., Hu, J. K., Kumari, S., Crampton, J., Baldeon, A. D., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606050113 · Cited by 425
Metadata
- Authors
- Kool, M., Fierens, K., & Lambrecht, B. N.
- Venue
- Journal of Medical Microbiology
- Publisher
- Microbiology Society
- Published
- 2012-07-01
- Volume
- 61
- Issue
- 7
- Pages
- 927-934
- ISSN
- 0022-2615 (ISSN-L)
- 1473-5644
- OpenAlex
- W2088139849
- Cited by
- 318
- References
- 67
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.